R Eastell
Overview
Explore the profile of R Eastell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
276
Citations
7925
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vilaca T, Evans A, Gossiel F, Paggiosi M, Eastell R, Walsh J
Eur J Endocrinol
. 2022 Sep;
187(6):743-750.
PMID: 36173650
Context: Obese (OB) adults (BMI ≥ 30) have a higher bone mineral density (BMD) and more favourable bone microarchitecture than normal-weight (NW) adults (BMI 18.5-24.9). Objective: The objective of this...
2.
Mattia L, Davis S, Mark-Wagstaff C, Abrahamsen B, Peel N, Eastell R, et al.
Bone
. 2022 Feb;
158:116347.
PMID: 35134571
Purpose: In Sheffield (UK), we introduced the PINP monitoring algorithm for the management of osteoporosis treatment delivered in primary care. Our aims were to evaluate whether this algorithm was associated...
3.
Gossiel F, Ugur A, Peel N, Walsh J, Eastell R
Osteoporos Int
. 2022 Feb;
33(6):1357-1363.
PMID: 35102444
Introduction: Bone turnover markers (BTMs) can be used to monitor response to osteoporosis treatment. However, some are affected by food intake and are not suitable to measure in a clinical...
4.
Schini M, Peel N, Toronjo-Urquiza L, Thomas E, Salam S, Khwaja A, et al.
Osteoporos Int
. 2021 Oct;
33(3):737-744.
PMID: 34654939
Introduction: Zoledronate is widely used for the treatment of osteoporosis. A potential side effect is acute kidney injury (AKI). Advice from the UK Medicines and Healthcare products Regulatory Agency (MHRA)...
5.
Cavalier E, Eastell R, Jorgensen N, Makris K, Tournis S, Vasikaran S, et al.
Calcif Tissue Int
. 2021 Apr;
108(6):825-826.
PMID: 33866379
No abstract available.
6.
Cavalier E, Eastell R, Jorgensen N, Makris K, Tournis S, Vasikaran S, et al.
Calcif Tissue Int
. 2021 Mar;
108(6):785-797.
PMID: 33661343
Background: Biochemical bone turnover markers are useful tools to assess bone remodeling. C-terminal telopeptide of type I collagen (ß-CTX) has been recommended as a reference marker for bone resorption in...
7.
8.
Lane N, Saag K, ONeill T, Manion M, Shah R, Klause U, et al.
Osteoporos Int
. 2021 Jan;
32(3):609.
PMID: 33464393
No abstract available.
9.
Lane N, Saag K, ONeill T, Manion M, Shah R, Klause U, et al.
Osteoporos Int
. 2020 Nov;
32(5):831-840.
PMID: 33236195
Introduction: The purpose of this study was to characterize bone turnover marker (BTM) testing patterns and estimate their clinical utility in treatment decision-making and fragility fracture risk in patients with...
10.